Declarations
•Ethics approval and consent to participate
Not applicable
•Consent for publication
Not applicable
•Availability of data and materials
Not applicable
•Competing interests
The authors declare that they have no competing interests
•Funding
Scholarship of Southeast University (Project No. 189351)
•Authors’ contributions
Xianqiang Yu completed the design and writing of the article all the content
•Acknowledgements
Not applicable
References
1 Sriram, K. and P. A. Insel (2020). ”A hypothesis for pathobiology and treatment of COVID-19: The centrality of ACE1/ACE2 imbalance.” Br J Pharmacol177 (21): 4825-4844.
2 Mille J,Cantor A,Zachariah P,Ahn D,Martinez M,Margolis K G. ”Gastrointestinal Symptoms as a Major Presentation Component of a Novel Multisystem Inflammatory Syndrome in Children That Is Related to Coronavirus Disease 2019: A Single Center Experience of 44 Cases.” Gastroenterology 2020 159 (4): 1571-1574.e2.
3 Cheng H,Wang Y,Wang G Q. ”Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19.” J Med Virol 2020 92 (7): 726-730.
4 Hanley B,Naresh K N,Roufosse C,Nicholson A G,Weir J,Cooke G S, et al. ”Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem study.” Lancet Microbe 2020 1(6): e245-e253.